Lupin announces acquisition of five legacy brands from A Menarini, reinforcing its presence in the Indian pharmaceutical market
Lupin gains ownership of Piclin, Menocytl, Sucramal O, Pyridium, and Distaclor, strengthening its product range
Lupin marketed these brands since 2021, and this acquisition marks a successful collaboration with A Menarini
Lupin aims to broaden its footprint in the Indian market, delivering greater value to stakeholders and communities
Menarini India expresses satisfaction with Lupin carrying forward the legacy of these brands, highlighting their strong collaboration
Menarini India, a subsidiary of the Menarini Group, celebrates the evolution of their partnership with Lupin
Lupin's strategic acquisition underscores its commitment to advancing the Indian pharmaceutical sector